Recombinant Human Erythropoietin (rHuEPO) In Combination with Chemotherapy Increases Breast Cancer Metastasis In Pre-Clinical Mouse Models.

被引：0
|
作者：
Xenocostas, Anargyros [1 ]
Hedley, Benjamin D. [1 ]
Chu, Jenny E. [2 ]
Ormond, D. George [2 ]
Beausoleil, Michel [2 ]
Boasie, Alexandra [2 ]
Allan, Alison L. [2 ]
机构：
[1] Univ Western Ontario, Dept Med, Schulich Sch Med & Dent, London, ON, Canada
[2] London Hlth Sci Ctr, London Reg Canc Program, London, ON, Canada
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1370 / 1370
页数：1
相关论文
共 50 条
  • [41] Developing combination therapies for hormone-refractory prostate cancer in a pre-clinical mouse model of the disease
    Abate-Shen, C.
    Kinkade, C. W.
    Castillo-Martin, M.
    Cordon-Cardo, C.
    EJC SUPPLEMENTS, 2008, 6 (12): : 7 - 7
  • [42] Data demonstrating the in vivo anti-tumor efficacy of thermosensitive liposome formulations of a drug combination in pre-clinical models of breast cancer
    Wang, Xuehan
    Regenold, Maximilian
    Dunne, Michael
    Bannigan, Pauric
    Allen, Christine
    DATA IN BRIEF, 2023, 50
  • [43] Effects of osteolytic bone metastases on bone mass and bone strength in the mouse: Validation of a pre-clinical model of breast cancer metastasis to bone.
    Allen, MJ
    Arrington, SA
    Margulies, BS
    Schoonmaker, JE
    Mann, KA
    Damron, TA
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S124 - S124
  • [44] Effects of JAK pathway inhibition in pre-clinical models of breast cancer bone marrow metastases
    Bottos, Alessia
    Gill, Jason
    Radimerski, Thomas
    Tzankov, Alexandar
    Wodnar-Filipowicz, Aleksandra
    Hynes, Nancy E.
    CANCER RESEARCH, 2015, 75
  • [45] Gene and microRNA Signatures of the Mesenchymal Epithelial Transition in Pre-Clinical Models of Inflammatory Breast Cancer
    Robertson, F. M.
    Player, A. N.
    Chu, K.
    Pickei, R.
    Ye, Z.
    Krishnamurthy, S.
    Liu, C-G
    Liu, X.
    Cristofanilli, M.
    Barsky, S.
    CANCER RESEARCH, 2010, 70
  • [46] Therapeutic efficacy of anti-MMP9 antibody in combination with nab-paclitaxel-based chemotherapy in pre-clinical models of pancreatic cancer
    Awasthi, Niranjan
    Mikels-Vigdal, Amanda J.
    Stefanutti, Erin
    Schwarz, Margaret A.
    Monahan, Sheena
    Smith, Victoria
    Schwarz, Roderich E.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (06) : 3878 - 3887
  • [47] Pre-clinical combination of a PARP inhibitor, talazoparib, and carboplatin in triple-negative breast cancer.
    Cotte, Alexia
    Beniey, Michele
    Haque, Takrima
    Bechir, Nelly
    Hubert, Audrey
    Diallo, Korotoum W.
    Tran-Thanh, Danh
    Hassan, Saima N.
    CANCER RESEARCH, 2021, 81 (13)
  • [48] Potential mouse tumor model for pre-clinical testing of Mage-specific breast cancer vaccines
    Sypniewska, RK
    Hoflack, L
    Bearss, DJ
    Gravekamp, C
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 74 (03) : 221 - 233
  • [49] Potential Mouse Tumor Model for Pre-Clinical Testing of Mage-Specific Breast Cancer Vaccines
    Roza K. Sypniewska
    Lieve Hoflack
    David J. Bearss
    Claudia Gravekamp
    Breast Cancer Research and Treatment, 2002, 74 : 221 - 233
  • [50] Development of advanced human immune system mouse models for pre-clinical research in immuno-oncology
    Mossu, A.
    Tschumi, B.
    ANNALS OF ONCOLOGY, 2019, 30
12345